Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Search Results

Refine Your Search

By Sector
Sort by: Date|Relevance

Buzz on the Bullboards: Rapid growth, or mild swelling?

It has been another rocky week for North American markets as traders continue to weigh the risks of inflation and the health of the financial sector. Canada’s own main stock index recently hit a two-week low, but in the face of every performance in the red...
Jonathon Brown | April 27, 2023 |

Technical Analyst: Gold Bull Market Well Established in Many Currencies

Technical analyst Clive Maund discusses the price of gold in various currencies and what he believes is ahead for gold, the U.S. dollar and the stock markets. We will start this update by looking at gold's price measured against various important currencies. These ...
Streetwise Reports | June 30, 2020 |

5 of the Biggest Financial Stories From 2019

According to the Chinese Zodiac Calendar, 2019 was the Year of the Pig. Investors and traders, I believe, will likely also remember it as the year of the bull. Every asset type, it seems—from large-caps to small-caps, from foreign to domestic, from gold to oil—fin...
Frank Holmes | December 30, 2019 |

Edesa Shares Double Upon Gaining Approval to Initiate Phase 2/3 COVID-19 Study

Shares of Edesa Biotech traded more than 100% higher after the company reported that it had received regulatory approval from Health Canada to initiate a Phase 2/3 study of its investigational drug EB05 in COVID-19. Clinical-stage biopharmaceutical company Edesa B...
Streetwise Reports | June 16, 2020 |

Interview: Saturn Oil & Gas CEO John Jeffrey on the future of the company and ESG

Saturn Oil & Gas is a TSX Venture Exchange issuer ( TSX-V: SOIL ) producing oil & gas with operations in the province of Saskatchewan, Canada. The company was created in 2017 from an arrangement and has since been led by CEO John Jeffrey. In the past fiscal year 2019, manage...
Mario Hose | December 10, 2020 |

A glide path to profitable gold production

What if a company could sidestep many of the hurdles to building a mine, and do so with a 2-million-ounce, high-grade gold resource? That’s the possibility that Grande Portage Resources (TSXV:GPG; OTCQB:GPTRF) offers investors. And yet, the ...
Research | October 25, 2024 |

Could There Finally Be an Effective Treatment for Alzheimer's Disease?

ProMIS' preclinical treatment could possibly outshine Biogen's candidate. Finding an effective treatment for Alzheimer's disease has been elusive as many seemingly promising avenues of research did not prove out in clinical trials. Biogen Inc. (BIIB:NASDAQ) appeared...
Streetwise Reports | November 7, 2019 |

Cabin Fever and the Price of Gold

I've had a few comments lately on the pieces I have been writing about where we stand politically and with the Corona Virus. One complained and said that he loves my comments on markets but I was getting too political. Of course I am. I thought we had two totally diff...
Streetwise Reports | May 1, 2020 |

A Life Sciences Project Accelerator Kicks into High Gear

XPhyto Therapeutics Corp. ( CSE: XPHY ) (FSE: 4XT) (OTC: XPHYF) has been a hot story lately, especially in Germany, due to its recent commercialization of a super-fast PCR test kit for definitively diagnosing COVID-19 infections in point-of-care settings. The company rec...
Marc Davis | May 10, 2021 |

XPhyto Therapeutics: Are they Selling the Solution to Germany’s Rapid Testing Crisis?

The Germans call it COVID-19 “rapid testing mania”. But like most manias, it has opened up a Pandora’s box of problems. As the speed of the vaccine rollout program falters in Europe, on-the-spot antigen testing continues to be the ...
Marc Davis | June 2, 2021 |
1 2